ERBB2 and breast cancer: Additionally, the molecular classification of BC is based on the expression levels of ER, PR, and HER2, allowing the stratification of this disease into three major subtypes: luminal, HER2 overexpression, and triple-negative breast cancer (TNBC) tumors (6).